dr. kaufman discusses durable responses to avelumab in merkel cell carcinoma
Published 7 years ago • 263 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
2:18
durable responses to avelumab in patients with merkel cell carcinoma
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
4:12
dr. howard kaufman on merkel cell carcinoma
-
1:03
role of immunotherapy in merkel cell carcinoma
-
5:55
targetting pd-l1 with avelumab in metastatic merkel cell carcinoma
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
1:19
dr. nghiem on response to immunotherapy in merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
1:15
how care for merkel cell carcinoma has been revolutionized in recent years
-
1:37
avelumab for treatment of metastatic merkel cell carcinoma
-
2:03
avelumab in merkel cell carcinoma – updates from asco 2017
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
-
3:06
asco 2024: dr. andrew brohl discusses merkel cell carcinoma
-
0:42
dr. kudchadkar on immunotherapy in merkel cell carcinoma
-
7:19
pembrolizumab yielded durable responses in patients with advanced merkel cell carcinoma
-
1:28
avelumab treatment in patients with metastatic merkel cell carcinoma
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
13:15
velocity vlog: advances in merkel cell carcinoma - new treatment approaches
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma